H5n1 Vaccine News
Most Popular H5n1 Vaccine Story
Roche suffers from Tamiflu resistance
It's a one-two punch for Roche from Tamiflu this week. No sooner had the drugmaker reported declining sales, in part on weaker sales of the antiviral drug, than the CDC announced that this year's flu... Read more...
Latest Headlines
- February 6, 2009
- May 19, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
